RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $930,000 | +11.1% | 33,945 | +9.1% | 0.00% | 0.0% |
| Q4 2018 | $837,000 | -48.3% | 31,125 | -44.0% | 0.00% | 0.0% |
| Q3 2018 | $1,620,000 | +153.9% | 55,532 | +172.1% | 0.00% | 0.0% |
| Q2 2018 | $638,000 | +114.8% | 20,406 | +36.8% | 0.00% | – |
| Q1 2018 | $297,000 | -29.5% | 14,915 | +2.9% | 0.00% | -100.0% |
| Q4 2017 | $421,000 | – | 14,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |